To see the other types of publications on this topic, follow the link: Pricing of medicines.

Dissertations / Theses on the topic 'Pricing of medicines'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 24 dissertations / theses for your research on the topic 'Pricing of medicines.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Villa, Federico. "The determinants of market access for medicines: theoretical issues and empirical evidence." Doctoral thesis, Università del Piemonte Orientale, 2021. https://hdl.handle.net/11579/148544.

Full text
Abstract:
To frame the determinants of drug prices within a complex regulatory system and how these determinants influence the P&R decisions of medicine, an analysis of the Italian reference context as a whole was done, starting from the trends in the use and consumption of drugs, to the analysis of the regulatory process and market access for specific categories of drugs, orphan drugs for rare diseases. Some of the system's shortcomings are the result of limited quality control as a whole over the years, which has led to the adoption of compartmentalized pharmaceutical policies without a medium-long t
APA, Harvard, Vancouver, ISO, and other styles
2

Villers, Trevor. "A thematic analysis of recent PHARMAC new medicines' subsidy decisions." Click here to access this resource online, 2008. http://hdl.handle.net/10292/386.

Full text
Abstract:
PHARMAC, the Pharmaceutical Management Agency, manages the Pharmaceutical Schedule on behalf of the Government. The Agency is tasked with securing the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided (§ 47 NZPHD Act, 2000). The Agency reports that it continues to improve New Zealanders’ access to funded medicines. In determining which pharmaceuticals to fund, PHARMAC’s Operating Policies and Procedures (OPPs) state that nine criteria guide its decision- making. The OPPs further state that PHARMAC can apply whatever
APA, Harvard, Vancouver, ISO, and other styles
3

Colak, Berna. "Generic Competition and Price Regulation in the European Union Pharmaceutical Market: The Case of Cardiovascular Medicines." Scholar Commons, 2014. https://scholarcommons.usf.edu/etd/5000.

Full text
Abstract:
The purpose of this dissertation is to examine the extent of competition between generic products and therapeutic substitutes under different regulatory regimes in the European Union (EU) pharmaceutical industry. In particular, this study investigates generic competition among the five largest European pharmaceutical markets; the United Kingdom, Germany, France, Italy and Spain, with comprehensive IMS data for 10 years (1994-2003), in order to estimate the effect of generic entry on drug prices at the product level. This analysis finds that generic entry has a negative effect on prices in coun
APA, Harvard, Vancouver, ISO, and other styles
4

Пашков, В. М. "Господарсько-правове забезпечення ціноутворення лікарських засобів в період пандемії COVID-19". Thesis, Сумський державний університет, 2020. https://essuir.sumdu.edu.ua/handle/123456789/79014.

Full text
Abstract:
Для висвітлення цього питання нам необхідно проаналізувати постанови КМУ від 03.04.2019 р. № 426 "Про референтне ціноутворення надеякі лікарські засоби, що закуповуються за бюджетні кошти", від 25.03.2009 р. № 333 "Деякі питання державного регулювання цін на лікарські засоби і вироби медичного призначення", від 27.09.2017 р. № 718 "Деякі питання закупівлі лікарських засобів", від 20.03.2020 р. № 224 "Про затвердження переліку лікарських засобів, медичних виробів та/або медичного обладнання, необхідних для здійснення заходів, спрямованих на запобігання виникненню і поширенню, локалізацію та лік
APA, Harvard, Vancouver, ISO, and other styles
5

Sugimoto, A. "Facing the challenges of high-cost medicines : multinational comparison of the pricing and reimbursement decision-making processes for the new Hepatitis C treatments." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2018. http://researchonline.lshtm.ac.uk/4649770/.

Full text
Abstract:
The therapeutic landscape of Hepatitis C virus (HCV) infection has changed dramatically since 2013 when “life-saving” direct-acting antivirals (HCV-DAAs) entered the global market. Although behind such a huge biomedical stride, their high prices have been criticised globally as a barrier to patient access and a threat to health care financing. In order to understand the emerging challenges of high-cost medicines, this study conducted a comparative multinational analysis of pricing and reimbursement decision-making processes for HCV-DAAs in Japan, the U.S. and England. Overall, the list prices
APA, Harvard, Vancouver, ISO, and other styles
6

Sweeny, Kim. "Accounting for growth in the Pharmaceutical Benefits Scheme." Thesis, full-text, 2008. https://vuir.vu.edu.au/1960/.

Full text
Abstract:
This thesis investigates the contribution to the growth in expenditure on medicines listed on the Pharmaceutical Benefits Scheme (PBS) from three inter-related sources: (i) the addition of new medicines offering an expanding range of treatments for disease, (ii) PBS processes for determining the prices of medicines and their conditions of listing and (iii) the demand by patients for PBS medicines. In doing so it uses trend analysis presented in both tabular and graphic form, expenditure decomposition techniques based on index and indicator numbers, and econometric analysis. Using novel techniq
APA, Harvard, Vancouver, ISO, and other styles
7

Sun, He, and 孙赫. "Differential pricing strategy in improving access to medicine in developing countries." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48425412.

Full text
Abstract:
Background Inadequate access to medicine is a key public health issue. It violates the basic human right, and impedes economics development and social progress. Differential pricing means to charge according to variant ability to pay for the same products. Since differential pricing has been successfully used into many business sectors, its adoption in pharmaceutical industry seems to be necessary and feasible to help improve access to medicine for developing countries. Objective This project is to review the effect of “differential pricing “in pharmaceutical industry and to discuss its c
APA, Harvard, Vancouver, ISO, and other styles
8

Horníková, Ivana. "Determinants of the prescription medicine prices in the Czech Republic." Master's thesis, Vysoká škola ekonomická v Praze, 2016. http://www.nusl.cz/ntk/nusl-264235.

Full text
Abstract:
This master thesis analyses factors that determine the prices of prescription medicine. The theoretical part is outlining the fundamentals of pharmaceutical market, identifying the main price components and determinants with main focus on pricing and reimbursement policies in the world. The empirical part is dedicated to the pharmaceutical market in the Czech Republic. It explores the impact of state regulatory measures such as internal and external reference pricing on the prescription medicine prices. A regression analysis was conducted to determine what factors have significant impact on th
APA, Harvard, Vancouver, ISO, and other styles
9

Bredenkamp, Jhandre. "The effect of generic medicine competition on the market share growth and pricing of originator brand medicine in the South African private pharmaceutical market." Thesis, Stellenbosch : Stellenbosch University, 2011. http://hdl.handle.net/10019.1/21380.

Full text
Abstract:
Thesis (MBA)--Stellenbosch University, 2011.<br>This study analyses the effects of generic medicine competition on the market share growth and pricing of originator brand medicine in the South African private pharmaceutical market. The study is based on five years (2005 to 2011) of IMS Health market share data for 39 originator brand drugs that have been exposed to competition from generic substitutes from 2001. The results show that, for all the drug molecules included in the study pooled together, the price of an originator brand medicine relative to the weighted average price of its generic
APA, Harvard, Vancouver, ISO, and other styles
10

Mutsago, Alither R. "Pharmaceutical pricing : assessing the impact of factors influencing HIV/AIDS and AIDS related medicine prices in Zimbabwe." Master's thesis, University of Cape Town, 2002. http://hdl.handle.net/11427/5728.

Full text
Abstract:
Bibliography: leaves 106-114.<br>HIV IAIDS death and mortality rates have proven to be one of the largest threats to the economies of many developing countries, in particular Zimbabwe. Twenty five percent of the adult population in Zimbabwe is HIV positive and it is estimated that at least 2000 people die every week of the disease. Consequently, there is an urgent need to find means and ways of reducing the number of premature deaths due to AIDS. Access to affordable drugs will have great impact on reducing these premature deaths in the country. However high AIDS and opportunistic infections d
APA, Harvard, Vancouver, ISO, and other styles
11

Noble-Luckhoff, Jennifer Anne. "An analysis of the impact of generic medicine reference pricing in a sector of the South African private healthcare insurance industry." Master's thesis, University of Cape Town, 2015. http://hdl.handle.net/11427/19883.

Full text
Abstract:
Includes bibliographical references<br>Background: Pharmaceuticals are responsible for a substantial percentage of the total cost of health care and continue to exceed economic growth and inflation. Generic medicines play an important role in limiting this expenditure, and consequently there is an international drive to implement pro - generic policies particularly in high income countries. One such policy is generic medicine reference pricing (GRP). Generic reference pricing sets a fixed maximum reimbursement amount for clusters of bio - equivalent drugs without placing any restrictions on t
APA, Harvard, Vancouver, ISO, and other styles
12

Katikireddi, Srinivasa Vittal. "The relationship between evidence and public health policy : case studies of the English public health white paper and minimum unit pricing of alcohol in Scotland." Thesis, University of Glasgow, 2013. http://theses.gla.ac.uk/4687/.

Full text
Abstract:
Background: Public health researchers and practitioners have repeatedly called for policy to be informed by academic evidence. The rise of the evidence-based medicine movement has demonstrated the potential benefits of using evidence for clinical decision-making. Recently, politicians and policy documents have echoed these calls for increased use of evidence in policymaking by drawing upon the discourse of evidence-based policy. However, efforts to understand the relationship between evidence and public health policy are underdeveloped and often make limited use of knowledge from other fields,
APA, Harvard, Vancouver, ISO, and other styles
13

Pinto, Marcus Paulo de Souza Ferreira. "Gestão de serviços veterinários: uma investigação sobre as práticas de custos, preços e rentabilidade sob o enfoque do conhecimento contábil." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/12/12136/tde-03122015-120450/.

Full text
Abstract:
Dentre os componentes da estratégia dos prestadores de serviços, a determinação de custos, margens e preços finais se constitui como elemento de elevada importância para manutenção da viabilidade econômica, dentro de um mercado que exige melhores serviços, com a manutenção de custos em patamares que permitam rentabilidade frente aos reembolsos e assegurem uma posição de captação e manutenção de clientes. As pequenas e médias empresas têm importante papel socio-econômico no cenário nacional, e há uma percepção de falta de práticas gerenciais adequadas no setor de medicina veterinária. Alega-se
APA, Harvard, Vancouver, ISO, and other styles
14

Wahlberg, Anna. "Continuity or Change? : Improved Understanding of Attitudes Towards Female Genital Cutting after Migration from Somalia to Sweden." Doctoral thesis, Uppsala universitet, Internationell mödra- och barnhälsovård (IMCH), 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-334703.

Full text
Abstract:
Do people’s attitudes towards female genital cutting (FGC) change after they migrate from a country where the practice is common, to one where it is not? Alongside increased levels of migration, this question is increasingly being raised. This thesis aimed to expand the understanding about attitudes towards FGC held by Somali men and women in Sweden, and thereby to identify potential factors that impede or facilitate the cessation of FGC. Cross-sectional questionnaire data were collected in four Swedish municipalities to assess attitudes to FGC. To further explore perceptions of FGC, as well a
APA, Harvard, Vancouver, ISO, and other styles
15

Rigal, Loïc. "Le droit des médicaments orphelins en Europe." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCB179.

Full text
Abstract:
La recherche dans le domaine des maladies sans traitement existant obéit à plusieurs impératifs définis par le législateur européen dans le règlement (CE) n° 141/2000 du 16 décembre 1999 concernant les médicaments orphelins. Les patients atteints de maladies rares et négligées ont le droit à « la même qualité de traitement que les autres » ce qui suppose de prendre les mesures d'incitation nécessaires pour « promouvoir la recherche, le développement et la commercialisation de traitements adéquats ». C'est un « domaine prioritaire ». Après avoir désigné les médicaments concernés, l'Union europé
APA, Harvard, Vancouver, ISO, and other styles
16

Malhotra, Prabodh. "Implementing TRIPS in India : implications for access to medicines." Thesis, 2009. https://vuir.vu.edu.au/30083/.

Full text
Abstract:
This thesis investigates the implications of implementing TRIPS in India for access to medicines drawing on three major factors: (i) the TRIPS agreement, (ii) the global pharmaceutical industry and (iii) the development of Indian pharmaceutical industry and the level of access to medicines in India. In doing so, the thesis examines the requirements of the TRIPS agreement and analyses the costs and benefits of its implementation, especially from a developing country view point. The fairness test shows that TRIPS prematurely forces developing countries to adopt protection standards, which a numb
APA, Harvard, Vancouver, ISO, and other styles
17

Neville, Warwick John. "Healing the nation : access to medicines under the Pharmaceutical Benefits Scheme - the jurisprudence from history." Phd thesis, 2007. http://hdl.handle.net/1885/150188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Santo, Jorge Miguel Ribeiro do Espírito. "A inovação e desenvolvimento de novos medicamentos, o acesso ao mercado e a sustentabilidade do sistemas de saúde: uma perspetiva futura." Master's thesis, 2019. http://hdl.handle.net/10316/88360.

Full text
Abstract:
Relatório de Estágio do Mestrado Integrado em Ciências Farmacêuticas apresentado à Faculdade de Farmácia<br>A Indústria Farmacêutica representa uma indústria-chave para o progresso tecnológico e científico da sociedade. Representa a concretização das Ciências da Saúde, interagindo diretamente com o governo e com sistemas de Saúde, contribuindo para o bem-estar da população ao aumentar a esperança média de vida, mas sobretudo a qualidade de vida dos doentes, através, principalmente, do medicamento.O medicamento e as terapias inovadoras têm um impacto profundo na sociedade, ao tornar doenças ant
APA, Harvard, Vancouver, ISO, and other styles
19

Chang, Wei-Cheng, and 張維正. "A study of the Exporting Pricing of Taiwan Made Chinese Medicinal Preparation." Thesis, 2010. http://ndltd.ncl.edu.tw/handle/22144686061589451282.

Full text
Abstract:
碩士<br>淡江大學<br>國際貿易學系國際企業學碩士班<br>98<br>This thesis empirically estimates the effect of exchange rate movement on the pricing behavior of the Taiwan made Chinese medicinal preparation products. The export unit values to the ten largest Chinese medicinal preparation products importing countries are the main focus. The annual data covering the 11 years period between 1997 and 2007 are chosen for the estimation. Estimations are carried out in accordance with the country specific, the high-and-low pricing area, the market size, and the stability of the associated markets. The estimated results show
APA, Harvard, Vancouver, ISO, and other styles
20

Thakur-Rajbansi, Shameen. "Impact of new medicine pricing regulations on independent community pharmacies : a KwaZulu-Natal study." Thesis, 2009. http://hdl.handle.net/10413/8131.

Full text
Abstract:
Pharmaceuticals are a crucial component of delivering healthcare, hence regulating pharmaceutical markets is a complex issue involving dynamic interplay of multiple actors. The South African healthcare industry is plagued with past problems and new ones created by cumbersome legislation, changing economic conditions and rapid cost escalation. The core objectives of the 2004 medicines pricing legislation were; effective care and use of resources; high quality services and responsiveness; accessibility and affordability of medicines for consumers. This study explores the impact of the new medici
APA, Harvard, Vancouver, ISO, and other styles
21

Colon, Jorge. "Service pricing for the healthcare professional." 2021. http://hdl.handle.net/10757/657213.

Full text
Abstract:
Festival de Innovación Educativa de la UPC. Ponente: Dr. Jorge Colon<br>El primer FIE de la UPC es un espacio de docentes para docentes, en donde se compartirán las estrategias innovadoras de aprendizaje que se han venido aplicando en los últimos meses de educación online. Es una oportunidad para intercambiar conocimiento, seguir aprendiendo y atrevernos a innovar como parte del proceso de enseñanza y aprendizaje.
APA, Harvard, Vancouver, ISO, and other styles
22

Fan, Chia-Yen, and 范嘉晏. "A Study for Integrating Purchasing and Pricing Decisions into Two Internet Marketing Models ─ an Example of Medicine Purchasing and Pricing of Some Regional Physician Association." Thesis, 2004. http://ndltd.ncl.edu.tw/handle/08423602226858646272.

Full text
Abstract:
碩士<br>輔仁大學<br>資訊管理學系<br>92<br>Using several pricing models, affiliated procurement, multi-objective programs, and the techniques and concept of data warehouse, this study presents a decision support framework of two Internet-marketing models for integrating purchasing and pricing strategies such that measurements of multiple criteria (i.e., cost, profit, satisfactions, etc.) can be interactively optimized. Medicine purchasing and pricing of some regional physician association is the empirical example of this study. In this case, web-based medicine purchasing and pricing models are c
APA, Harvard, Vancouver, ISO, and other styles
23

Huang, Yun-Hua, and 黃韻華. "National Health Insurance Financial Problem and the “Black Hole” of Medicine Pricing- An Empirical Study of System Dynamics Approach." Thesis, 2008. http://ndltd.ncl.edu.tw/handle/07690183474175691897.

Full text
Abstract:
碩士<br>中原大學<br>企業管理研究所<br>96<br>In order to improve our citizenly health, the National Health Insurance (NHI) policy was officially implemented in Taiwan on March 1995. Even if NHI had high satisfaction, the insurance premium bases harden into stone; tariff was not easy to adjustment; the demand for medical treatment increased and the trading process was inefficiently all of them were causing the financial deficit. The study use system dynamics research process and Vensim software to build the relationship between insured, insurer and medical institution. Using the model develop the workable po
APA, Harvard, Vancouver, ISO, and other styles
24

Beutlová, Lenka. "Cenová regulace léčiv." Master's thesis, 2019. http://www.nusl.cz/ntk/nusl-397239.

Full text
Abstract:
Price regulation of preparations for medical treatment Abstract The present master thesis describes and analyzes the system of medicinal product's pricing regulation in the Czech Republic after the year 1989. The aim is to execute an analysis of the current legal regulation in the context of previous regulation, of particular phases of the process of regulation of medicinal product's prices and to provide a summary of the principles and recommendations as well as to attempt a proposition of future development possibilities. The thesis focuses on Czech legal regulation, decision-making by the j
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!